---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-022876"
form_type: "8-K"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2024-07-17T23:59:59+00:00"
generated_at: "2026-05-31T20:05:47.382501+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cassava Sciences CEO Remi Barbier resigns; Rick Barry named Executive Chairman; CEO search begins

## Summary
- CEO/President Remi Barbier resigns effective Sep 13, 2024; also resigns as Chairman and Board member immediately.
- SVP Neuroscience Lindsay Burns steps down; enters 1-year consulting agreement at $500/hour; receives $0.5M severance.
- Independent director Rick Barry appointed Executive Chairman and principal executive officer; CEO search launched.
- Board adds Pierre Gravier as Audit Committee Chair, Robert Anderson as Nominating & Governance Committee Chair.
- Company pledges enhanced transparency: quarterly analyst calls and timely posting of Phase 3 trial results to clinicaltrials.gov.

## SEC filing metadata
- accession: 0001437749-24-022876
- form_type: 8-K
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2024-07-17T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000143774924022876/0001437749-24-022876-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000143774924022876/sava20240717_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-022876
- JSON: https://secwatch.observer/filing/0001437749-24-022876.json
- Plain text: https://secwatch.observer/filing/0001437749-24-022876.txt

## Key facts
- Executive change
  Remi Barbier resigned as Chairman of the Board at FILANA THERAPEUTICS, INC..
  - Action: resigned
  - Role: Chairman of the Board
  source text: In addition, on July 15, 2024, the Company’s Board of Directors (the “ Board ”) accepted Mr. Barbier’s resignation as Chairman of the Board and from board membership, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069530/000143774924022876/0001437749-24-022876-index.htm
- Executive change
  Remi Barbier resigned as President and Chief Executive Officer at FILANA THERAPEUTICS, INC..
  - Action: resigned
  - Role: President and Chief Executive Officer
  source text: On July 15, 2024, Remi Barbier, President and Chief Executive Officer of Cassava Sciences, Inc. (the “ Company ” or “ Cassava ”) resigned from the Company, effective as of September 13, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069530/000143774924022876/0001437749-24-022876-index.htm
- Executive change
  Richard J. Barry was appointed as Executive Chairman at FILANA THERAPEUTICS, INC..
  - Action: appointed
  - Role: Executive Chairman
  source text: On July 15, 2024, Richard J. Barry, an independent director and currently the Chair of the Company’s Audit and Nominating & Governance Committees, was appointed by the Board as its Executive Chairman.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069530/000143774924022876/0001437749-24-022876-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.